cached image

Raphael Mechoulam - Publications

Pharmacy Hebrew University, Jerusalem, Jerusalem, Israel 
chemistry and pharmacology of cannabinoids

142 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Carmon I, Zecharyahu L, Elayyan J, Meka SRK, Reich E, Kandel L, Bilkei-Gorzo A, Zimmer A, Mechoulam R, Kravchenko-Balasha N, Dvir-Ginzberg M. HU308 Mitigates Osteoarthritis by Stimulating Sox9-Related Networks of Carbohydrate Metabolism. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. PMID 36350089 DOI: 10.1002/jbmr.4741  0.415
2019 Rock EM, Ayoub SM, Limebeer CL, Gene A, Wills KL, DeVuono MV, Smoum R, Di Marzo V, Lichtman AH, Mechoulam R, Parker LA. Acute naloxone-precipitated morphine withdrawal elicits nausea-like somatic behaviors in rats in a manner suppressed by N-oleoylglycine. Psychopharmacology. PMID 31712968 DOI: 10.1007/S00213-019-05373-2  0.304
2019 Pacher P, Kogan NM, Mechoulam R. Beyond THC and Endocannabinoids. Annual Review of Pharmacology and Toxicology. PMID 31580774 DOI: 10.1146/Annurev-Pharmtox-010818-021441  0.336
2019 Petrie GN, Wills KL, Piscitelli F, Smoum R, Limebeer CL, Rock EM, Humphrey AE, Sheppard-Perkins M, Lichtman AH, Mechoulam R, Di Marzo V, Parker LA. Oleoyl glycine: interference with the aversive effects of acute naloxone-precipitated MWD, but not morphine reward, in male Sprague-Dawley rats. Psychopharmacology. PMID 30993360 DOI: 10.1007/S00213-019-05237-9  0.354
2019 Alcina AG, Stevenson LA, Haj C, Smoum R, Mechoulam R, Hislop JN, Pertwee RG. A synthetic analogue of cannabidiolic acid that acts like a positive allosteric modulator at 5-HT1A receptors British Journal of Pharmacology. 176: 3011-3012. DOI: 10.1111/Bph.14681  0.349
2018 Donvito G, Piscitelli F, Muldoon P, Jackson A, Vitale RM, D'Aniello E, Giordano C, Ignatowska-Jankowska BM, Mustafa MA, Guida F, Petrie GN, Parker L, Smoum R, Sim-Selley L, Maione S, ... ... Mechoulam R, et al. N-Oleoyl-glycine reduces nicotine reward and withdrawal in mice. Neuropharmacology. PMID 29567093 DOI: 10.1016/J.Neuropharm.2018.03.020  0.301
2017 Pertwee RG, Rock EM, Guenther K, Limebeer CL, Stevenson LA, Haj C, Smoum R, Parker LA, Mechoulam R. Cannabidiolic acid methyl ester, a stable synthetic analogue of cannabidiolic acid, can produce 5-HT1A receptor-mediated suppression of nausea and anxiety in rats. British Journal of Pharmacology. PMID 29057454 DOI: 10.1111/Bph.14073  0.346
2017 Silva NR, Gomes FV, Fonseca MD, Mechoulam R, Breuer A, Cunha TM, Guimarães FS. Antinociceptive effects of HUF-101, a fluorinated cannabidiol derivative. Progress in Neuro-Psychopharmacology & Biological Psychiatry. PMID 28720466 DOI: 10.1016/J.Pnpbp.2017.07.012  0.368
2016 Breuer A, Haj CG, Fogaça MV, Gomes FV, Silva NR, Pedrazzi JF, Del Bel EA, Hallak JC, Crippa JA, Zuardi AW, Mechoulam R, Guimarães FS. Fluorinated Cannabidiol Derivatives: Enhancement of Activity in Mice Models Predictive of Anxiolytic, Antidepressant and Antipsychotic Effects. Plos One. 11: e0158779. PMID 27416026 DOI: 10.1371/Journal.Pone.0158779  0.327
2016 Rock EM, Boulet N, Limebeer CL, Mechoulam R, Parker LA. Cannabinoid 2 (CB2) receptor agonism reduces lithium chloride-induced vomiting in Suncus murinus and nausea-induced conditioned gaping in rats. European Journal of Pharmacology. PMID 27263826 DOI: 10.1016/J.Ejphar.2016.06.001  0.38
2015 Maslov LN, Khaliulin I, Zhang Y, Krylatov AV, Naryzhnaya NV, Mechoulam R, Petrocellis L, Downey JM. Prospects for Creation of Cardioprotective Drugs Based on Cannabinoid Receptor Agonists. Journal of Cardiovascular Pharmacology and Therapeutics. PMID 26487546 DOI: 10.1177/1074248415612593  0.333
2015 Haj CG, Sumariwalla PF, Hanuš L, Kogan NM, Yektin Z, Mechoulam R, Feldmann M, Gallily R. HU-444, a Novel, Potent Anti-Inflammatory, Nonpsychotropic Cannabinoid. The Journal of Pharmacology and Experimental Therapeutics. 355: 66-75. PMID 26272937 DOI: 10.1124/Jpet.115.226100  0.338
2015 Kozela E, Haj C, Hanuš L, Chourasia M, Shurki A, Juknat A, Kaushansky N, Mechoulam R, Vogel Z. HU-446 and HU-465, Derivatives of the Non-psychoactive Cannabinoid Cannabidiol, Decrease the Activation of Encephalitogenic T Cells. Chemical Biology & Drug Design. PMID 26259697 DOI: 10.1111/Cbdd.12637  0.346
2015 Smoum R, Baraghithy S, Chourasia M, Breuer A, Mussai N, Attar-Namdar M, Kogan NM, Raphael B, Bolognini D, Cascio MG, Marini P, Pertwee RG, Shurki A, Mechoulam R, Bab I. CB2 cannabinoid receptor agonist enantiomers HU-433 and HU-308: An inverse relationship between binding affinity and biological potency. Proceedings of the National Academy of Sciences of the United States of America. 112: 8774-9. PMID 26124120 DOI: 10.1073/Pnas.1503395112  0.374
2015 Maccarrone M, Bab I, Bíró T, Cabral GA, Dey SK, Di Marzo V, Konje JC, Kunos G, Mechoulam R, Pacher P, Sharkey KA, Zimmer A. Endocannabinoid signaling at the periphery: 50 years after THC. Trends in Pharmacological Sciences. 36: 277-96. PMID 25796370 DOI: 10.1016/J.Tips.2015.02.008  0.446
2015 Mann A, Smoum R, Trembovler V, Alexandrovich A, Breuer A, Mechoulam R, Shohami E. Palmitoyl Serine: An Endogenous Neuroprotective Endocannabinoid-Like Entity After Traumatic Brain Injury. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 10: 356-63. PMID 25721934 DOI: 10.1007/S11481-015-9595-Z  0.353
2015 Wasserman E, Tam J, Mechoulam R, Zimmer A, Maor G, Bab I. CB1 cannabinoid receptors mediate endochondral skeletal growth attenuation by Δ9-tetrahydrocannabinol. Annals of the New York Academy of Sciences. 1335: 110-9. PMID 25573322 DOI: 10.1111/Nyas.12642  0.501
2014 Mechoulam R, Hanuš LO, Pertwee R, Howlett AC. Early phytocannabinoid chemistry to endocannabinoids and beyond Nature Reviews Neuroscience. 15: 757-764. PMID 25315390 DOI: 10.1038/Nrn3811  0.31
2013 Espejo-Porras F, Fernández-Ruiz J, Pertwee RG, Mechoulam R, García C. Motor effects of the non-psychotropic phytocannabinoid cannabidiol that are mediated by 5-HT1A receptors. Neuropharmacology. 75: 155-63. PMID 23924692 DOI: 10.1016/J.Neuropharm.2013.07.024  0.366
2013 Cohen-Yeshurun A, Willner D, Trembovler V, Alexandrovich A, Mechoulam R, Shohami E, Leker RR. N-arachidonoyl-L-serine (AraS) possesses proneurogenic properties in vitro and in vivo after traumatic brain injury Journal of Cerebral Blood Flow and Metabolism. 33: 1242-1250. PMID 23695434 DOI: 10.1038/Jcbfm.2013.75  0.317
2013 Mechoulam R, Parker LA. The endocannabinoid system and the brain Annual Review of Psychology. 64: 21-47. PMID 22804774 DOI: 10.1146/Annurev-Psych-113011-143739  0.326
2013 Fernández-Ruiz J, Sagredo O, Pazos MR, García C, Pertwee R, Mechoulam R, Martínez-Orgado J. Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid? British Journal of Clinical Pharmacology. 75: 323-33. PMID 22625422 DOI: 10.1111/J.1365-2125.2012.04341.X  0.366
2013 Maslov LN, Lishmanov YB, Oeltgen P, Pei JM, Krylatov AV, Barzakh EI, Portnichenko AG, Mechoulam R. Effects of preconditioning on coronary perfusion in cardiac ischemia and reperfusion Neuroscience and Behavioral Physiology. 43: 1039-1048. DOI: 10.1007/S11055-013-9848-3  0.318
2013 Maslov LN, Headrick JP, Mechoulam R, Krylatov AV, Lishmanov AY, Barzakh EI, Naryzhnaya NV, Zhang Y. The role of receptor transactivation in the cardioprotective effects of preconditioning and postconditioning Neuroscience and Behavioral Physiology. 43: 1015-1022. DOI: 10.1007/S11055-013-9844-7  0.355
2012 Limebeer CL, Rock EM, Mechoulam R, Parker LA. The anti-nausea effects of CB1 agonists are mediated by an action at the visceral insular cortex British Journal of Pharmacology. 167: 1126-1136. PMID 22671779 DOI: 10.1111/J.1476-5381.2012.02066.X  0.376
2012 Sticht MA, Long JZ, Rock EM, Limebeer CL, Mechoulam R, Cravatt BF, Parker LA. Inhibition of monoacylglycerol lipase attenuates vomiting in Suncus murinus and 2-arachidonoyl glycerol attenuates nausea in rats. British Journal of Pharmacology. 165: 2425-35. PMID 21470205 DOI: 10.1111/J.1476-5381.2011.01407.X  0.365
2011 Bab I, Smoum R, Bradshaw H, Mechoulam R. Skeletal lipidomics: Regulation of bone metabolism by fatty acid amide family British Journal of Pharmacology. 163: 1441-1446. PMID 21557736 DOI: 10.1111/J.1476-5381.2011.01474.X  0.315
2011 Fernández-Ruiz J, Moreno-Martet M, Rodríguez-Cueto C, Palomo-Garo C, Gómez-Cañas M, Valdeolivas S, Guaza C, Romero J, Guzmán M, Mechoulam R, Ramos JA. Prospects for cannabinoid therapies in basal ganglia disorders. British Journal of Pharmacology. 163: 1365-78. PMID 21545415 DOI: 10.1111/J.1476-5381.2011.01365.X  0.323
2011 Cohen-Yeshurun A, Trembovler V, Alexandrovich A, Ryberg E, Greasley PJ, Mechoulam R, Shohami E, Leker RR. N-arachidonoyl-L-serine is neuroprotective after traumatic brain injury by reducing apoptosis Journal of Cerebral Blood Flow and Metabolism. 31: 1768-1777. PMID 21505478 DOI: 10.1038/Jcbfm.2011.53  0.342
2011 Di Marzo V, Piscitelli F, Mechoulam R. Cannabinoids and endocannabinoids in metabolic disorders with focus on diabetes. Handbook of Experimental Pharmacology. 75-104. PMID 21484568 DOI: 10.1007/978-3-642-17214-4_4  0.301
2011 Shohami E, Cohen-Yeshurun A, Magid L, Algali M, Mechoulam R. Endocannabinoids and traumatic brain injury. British Journal of Pharmacology. 163: 1402-10. PMID 21418185 DOI: 10.1111/J.1476-5381.2011.01343.X  0.329
2011 Martín-Moreno AM, Reigada D, Ramírez BG, Mechoulam R, Innamorato N, Cuadrado A, de Ceballos ML. Cannabidiol and other cannabinoids reduce microglial activation in vitro and in vivo: relevance to Alzheimer's disease. Molecular Pharmacology. 79: 964-73. PMID 21350020 DOI: 10.1124/Mol.111.071290  0.366
2011 Pacher P, Mechoulam R. Is lipid signaling through cannabinoid 2 receptors part of a protective system? Progress in Lipid Research. 50: 193-211. PMID 21295074 DOI: 10.1016/J.Plipres.2011.01.001  0.361
2011 Ofek O, Attar-Namdar M, Kram V, Dvir-Ginzberg M, Mechoulam R, Zimmer A, Frenkel B, Shohami E, Bab I. CB2 cannabinoid receptor targets mitogenic Gi protein-cyclin D1 axis in osteoblasts. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 26: 308-16. PMID 20803555 DOI: 10.1002/Jbmr.228  0.479
2010 Pertwee RG, Howlett AC, Abood ME, Alexander SP, Di Marzo V, Elphick MR, Greasley PJ, Hansen HS, Kunos G, Mackie K, Mechoulam R, Ross RA. International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CBâ‚‚. Pharmacological Reviews. 62: 588-631. PMID 21079038 DOI: 10.1124/Pr.110.003004  0.368
2010 Brown I, Cascio MG, Wahle KW, Smoum R, Mechoulam R, Ross RA, Pertwee RG, Heys SD. Cannabinoid receptor-dependent and -independent anti-proliferative effects of omega-3 ethanolamides in androgen receptor-positive and -negative prostate cancer cell lines. Carcinogenesis. 31: 1584-91. PMID 20660502 DOI: 10.1016/J.Ejso.2010.08.080  0.365
2010 Hanuš LO, Mechoulam R. Novel natural and synthetic ligands of the endocannabinoid system Current Medicinal Chemistry. 17: 1341-1359. PMID 20166928 DOI: 10.2174/092986710790980096  0.351
2010 Magen I, Avraham Y, Ackerman Z, Vorobiev L, Mechoulam R, Berry EM. Cannabidiol ameliorates cognitive and motor impairments in bile-duct ligated mice via 5-HT 1A receptor activation British Journal of Pharmacology. 159: 950-957. PMID 20128798 DOI: 10.1111/J.1476-5381.2009.00589.X  0.308
2009 Izzo AA, Borrelli F, Capasso R, Di Marzo V, Mechoulam R. Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb. Trends in Pharmacological Sciences. 30: 515-27. PMID 19729208 DOI: 10.1016/J.Tips.2009.07.006  0.354
2009 Sagredo O, González S, Aroyo I, Pazos MR, Benito C, Lastres-Becker I, Romero JP, Tolón RM, Mechoulam R, Brouillet E, Romero J, Fernández-Ruiz J. Cannabinoid CB2 receptor agonists protect the striatum against malonate toxicity: relevance for Huntington's disease. Glia. 57: 1154-67. PMID 19115380 DOI: 10.1002/Glia.20838  0.394
2009 Avraham Y, Zolotarev O, Grigoriadis NC, Pautahidis T, Magen I, Vorobiav L, Zimmer A, Ilan Y, Mechoulam R, Berry EM. Cannabinoids and capsaicin improve liver function following thioacetamide-induced acute injury in mice (American Journal of Gastroenterology (2009) 103, (3047-3056) DOI: 10.1111/j.1572-0241.2008.02155.x) American Journal of Gastroenterology. 104: 801. DOI: 10.1038/Ajg.2009.98  0.432
2009 Ofek O, Goldfine L, Bajayo A, Melamed E, Gabet Y, Shohami E, Mechoulam R, Bab I. Skeletal anabolic activity of cannabinoid receptor agonists Bone. 44. DOI: 10.1016/J.Bone.2009.01.092  0.367
2008 Avraham Y, Zolotarev O, Grigoriadis NC, Poutahidis T, Pautahidis T, Magen I, Vorobiav L, Zimmer A, Ilan Y, Mechoulam R, Berry EM. Cannabinoids and capsaicin improve liver function following thioacetamide-induced acute injury in mice. The American Journal of Gastroenterology. 103: 3047-56. PMID 19086956 DOI: 10.1111/J.1572-0241.2008.02155.X  0.517
2008 Patinkin D, Milman G, Breuer A, Fride E, Mechoulam R. Endocannabinoids as positive or negative factors in hematopoietic cell migration and differentiation European Journal of Pharmacology. 595: 1-6. PMID 18778813 DOI: 10.1016/J.Ejphar.2008.05.002  0.769
2008 Moussaieff A, Rimmerman N, Bregman T, Straiker A, Felder CC, Shoham S, Kashman Y, Huang SM, Lee H, Shohami E, Mackie K, Caterina MJ, Walker JM, Fride E, Mechoulam R. Incensole acetate, an incense component, elicits psychoactivity by activating TRPV3 channels in the brain. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 22: 3024-34. PMID 18492727 DOI: 10.1096/Fj.07-101865  0.757
2008 Moussaieff A, Shein NA, Tsenter J, Grigoriadis S, Simeonidou C, Alexandrovich AG, Trembovler V, Ben-Neriah Y, Schmitz ML, Fiebich BL, Munoz E, Mechoulam R, Shohami E. Incensole acetate: a novel neuroprotective agent isolated from Boswellia carterii. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 28: 1341-52. PMID 18414499 DOI: 10.1038/Jcbfm.2008.28  0.304
2008 Palazuelos J, Davoust N, Julien B, Hatterer E, Aguado T, Mechoulam R, Benito C, Romero J, Silva A, Guzmán M, Nataf S, Galve-Roperh I. The CB(2) cannabinoid receptor controls myeloid progenitor trafficking: involvement in the pathogenesis of an animal model of multiple sclerosis. The Journal of Biological Chemistry. 283: 13320-9. PMID 18334483 DOI: 10.1074/Jbc.M707960200  0.362
2008 Bermúdez-Silva FJ, Suárez J, Baixeras E, Cobo N, Bautista D, Cuesta-Muñoz AL, Fuentes E, Juan-Pico P, Castro MJ, Milman G, Mechoulam R, Nadal A, Rodríguez de Fonseca F. Presence of functional cannabinoid receptors in human endocrine pancreas. Diabetologia. 51: 476-87. PMID 18092149 DOI: 10.1007/S00125-007-0890-Y  0.314
2008 McHugh D, Tanner C, Mechoulam R, Pertwee RG, Ross RA. Inhibition of human neutrophil chemotaxis by endogenous cannabinoids and phytocannabinoids: evidence for a site distinct from CB1 and CB2. Molecular Pharmacology. 73: 441-50. PMID 17965195 DOI: 10.1124/Mol.107.041863  0.361
2008 Tam J, Trembovler V, Di Marzo V, Petrosino S, Leo G, Alexandrovich A, Regev E, Casap N, Shteyer A, Ledent C, Karsak M, Zimmer A, Mechoulam R, Yirmiya R, Shohami E, et al. The cannabinoid CB1 receptor regulates bone formation by modulating adrenergic signaling. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 22: 285-94. PMID 17704191 DOI: 10.1096/Fj.06-7957Com  0.481
2007 Mechoulam R, Shohami E. Endocannabinoids and traumatic brain injury. Molecular Neurobiology. 36: 68-74. PMID 17952651 DOI: 10.1007/S12035-007-8008-6  0.309
2007 Moussaieff A, Shohami E, Kashman Y, Fride E, Schmitz ML, Renner F, Fiebich BL, Munoz E, Ben-Neriah Y, Mechoulam R. Incensole acetate, a novel anti-inflammatory compound isolated from Boswellia resin, inhibits nuclear factor-kappa B activation. Molecular Pharmacology. 72: 1657-64. PMID 17895408 DOI: 10.1124/Mol.107.038810  0.746
2007 Sagredo O, Ramos JA, Decio A, Mechoulam R, Fernández-Ruiz J. Cannabidiol reduced the striatal atrophy caused 3-nitropropionic acid in vivo by mechanisms independent of the activation of cannabinoid, vanilloid TRPV1 and adenosine A2A receptors. The European Journal of Neuroscience. 26: 843-51. PMID 17672854 DOI: 10.1111/J.1460-9568.2007.05717.X  0.341
2007 Karsak M, Gaffal E, Date R, Wang-Eckhardt L, Rehnelt J, Petrosino S, Starowicz K, Steuder R, Schlicker E, Cravatt B, Mechoulam R, Buettner R, Werner S, Di Marzo V, Tüting T, et al. Attenuation of allergic contact dermatitis through the endocannabinoid system Science. 316: 1494-1497. PMID 17556587 DOI: 10.1126/Science.1142265  0.503
2007 García-Arencibia M, González S, de Lago E, Ramos JA, Mechoulam R, Fernández-Ruiz J. Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson's disease: importance of antioxidant and cannabinoid receptor-independent properties. Brain Research. 1134: 162-70. PMID 17196181 DOI: 10.1016/J.Brainres.2006.11.063  0.352
2006 Palazuelos J, Aguado T, Egia A, Mechoulam R, Guzmán M, Galve-Roperh I. Non-psychoactive CB2 cannabinoid agonists stimulate neural progenitor proliferation. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 20: 2405-7. PMID 17015409 DOI: 10.1096/Fj.06-6164Fje  0.378
2006 Tam J, Ofek O, Fride E, Ledent C, Gabet Y, M̈uller R, Zimmer A, Mackie K, Mechoulam R, Shohami E, Bab I. Involvement of neuronal cannabinoid receptor CB1 in regulation of bone mass and bone remodeling Molecular Pharmacology. 70: 786-792. PMID 16772520 DOI: 10.1124/Mol.106.026435  0.765
2006 Shohami E, Mechoulam R. Multiple sclerosis may disrupt endocannabinoid brain protection mechanism. Proceedings of the National Academy of Sciences of the United States of America. 103: 6087-8. PMID 16606822 DOI: 10.1073/Pnas.0601847103  0.324
2006 Mechoulam R, Berry EM, Avraham Y, Di Marzo V, Fride E. Endocannabinoids, feeding and suckling - From our perspective International Journal of Obesity. 30: S24-S28. PMID 16570101 DOI: 10.1038/Sj.Ijo.0803274  0.759
2006 Milman G, Maor Y, Abu-Lafi S, Horowitz M, Gallily R, Batkai S, Mo FM, Offertaler L, Pacher P, Kunos G, Mechoulam R. N-arachidonoyl L-serine, an endocannabinoid-like brain constituent with vasodilatory properties. Proceedings of the National Academy of Sciences of the United States of America. 103: 2428-33. PMID 16467152 DOI: 10.1073/Pnas.0510676103  0.378
2006 Ofek O, Karsak M, Leclerc N, Fogel M, Frenkel B, Wright K, Tam J, Attar-Namdar M, Kram V, Shohami E, Mechoulam R, Zimmer A, Bab I. Peripheral cannabinoid receptor, CB2, regulates bone mass. Proceedings of the National Academy of Sciences of the United States of America. 103: 696-701. PMID 16407142 DOI: 10.1073/Pnas.0504187103  0.489
2006 Avraham Y, Israeli E, Gabbay E, Okun A, Zolotarev O, Silberman I, Ganzburg V, Dagon Y, Magen I, Vorobia L, Pappo O, Mechoulam R, Ilan Y, Berry EM. Endocannabinoids affect neurological and cognitive function in thioacetamide-induced hepatic encephalopathy in mice. Neurobiology of Disease. 21: 237-45. PMID 16102970 DOI: 10.1016/J.Nbd.2005.07.008  0.386
2005 Sarne Y, Mechoulam R. Cannabinoids: between neuroprotection and neurotoxicity. Current Drug Targets. Cns and Neurological Disorders. 4: 677-84. PMID 16375685 DOI: 10.2174/156800705774933005  0.327
2005 Unzicker C, Erberich H, Moldrich G, Woldt H, Bulla J, Mechoulam R, Ehrenreich H, Sirén AL. Hippocampal cannabinoid-1 receptor upregulation upon endothelin-B receptor deficiency: a neuroprotective substitution effect? Neurochemical Research. 30: 1305-9. PMID 16341592 DOI: 10.1007/S11064-005-8802-3  0.359
2005 Fride E, Suris R, Weidenfeld J, Mechoulam R. Differential response to acute and repeated stress in cannabinoid CB 1 receptor knockout newborn and adult mice Behavioural Pharmacology. 16: 431-440. PMID 16148448 DOI: 10.1097/00008877-200509000-00016  0.751
2005 Moussaieff A, Fride E, Amar Z, Lev E, Steinberg D, Gallily R, Mechoulam R. The Jerusalem Balsam: From the Franciscan Monastery in the old city of Jerusalem to Martindale 33 Journal of Ethnopharmacology. 101: 16-26. PMID 15963667 DOI: 10.1016/J.Jep.2005.03.028  0.734
2005 Pertwee RG, Thomas A, Stevenson LA, Maor Y, Mechoulam R. Evidence that (-)-7-hydroxy-4'-dimethylheptyl-cannabidiol activates a non-CB(1), non-CB(2), non-TRPV1 target in the mouse vas deferens. Neuropharmacology. 48: 1139-46. PMID 15910889 DOI: 10.1016/J.Neuropharm.2005.01.010  0.357
2005 Lastres-Becker I, Molina-Holgado F, Ramos JA, Mechoulam R, Fernández-Ruiz J. Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: relevance to Parkinson's disease. Neurobiology of Disease. 19: 96-107. PMID 15837565 DOI: 10.1016/J.Nbd.2004.11.009  0.359
2005 Hanus LO, Tchilibon S, Ponde DE, Breuer A, Fride E, Mechoulam R. Enantiomeric cannabidiol derivatives: synthesis and binding to cannabinoid receptors. Organic & Biomolecular Chemistry. 3: 1116-23. PMID 15750656 DOI: 10.1039/B416943C  0.776
2005 Panikashvili D, Mechoulam R, Beni SM, Alexandrovich A, Shohami E. CB1 cannabinoid receptors are involved in neuroprotection via NF-kappa B inhibition. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 25: 477-84. PMID 15729296 DOI: 10.1038/Sj.Jcbfm.9600047  0.37
2005 Maccarrone M, Fride E, Bisogno T, Bari M, Cascio MG, Battista N, Finazzi Agrò A, Suris R, Mechoulam R, Di Marzo V. Up-regulation of the endocannabinoid system in the uterus of leptin knockout (ob/ob) mice and implications for fertility Molecular Human Reproduction. 11: 21-28. PMID 15563449 DOI: 10.1093/Molehr/Gah130  0.763
2005 Mechoulam R, Sumariwalla PF, Feldmann M, Gallily R. Cannabinoids in models of chronic inflammatory conditions Phytochemistry Reviews. 4: 11-18. DOI: 10.1007/S11101-004-1534-1  0.325
2004 Fride E, Feigin C, Ponde DE, Breuer A, Hanus L, Arshavsky N, Mechoulam R. (+)-Cannabidiol analogues which bind cannabinoid receptors but exert peripheral activity only. European Journal of Pharmacology. 506: 179-88. PMID 15588739 DOI: 10.1016/J.Ejphar.2004.10.049  0.793
2004 Golech SA, McCarron RM, Chen Y, Bembry J, Lenz F, Mechoulam R, Shohami E, Spatz M. Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors. Brain Research. Molecular Brain Research. 132: 87-92. PMID 15548432 DOI: 10.1016/J.Molbrainres.2004.08.025  0.401
2004 Sumariwalla PF, Gallily R, Tchilibon S, Fride E, Mechoulam R, Feldmann M. A Novel Synthetic, Nonpsychoactive Cannabinoid Acid (HU-320) with Antiinflammatory Properties in Murine Collagen-Induced Arthritis Arthritis and Rheumatism. 50: 985-998. PMID 15022343 DOI: 10.1002/Art.20050  0.753
2003 Parker LA, Mechoulam R. Cannabinoid Agonists and Antagonists Modulate Lithium-induced Conditioned Gaping in Rats Integrative Physiological and Behavioral Science. 38: 133-145. PMID 14527182 DOI: 10.1007/Bf02688831  0.3
2003 Mechoulam R, Lichtman AH. Neuroscience. Stout guards of the central nervous system. Science (New York, N.Y.). 302: 65-7. PMID 14526067 DOI: 10.1126/Science.1091256  0.314
2003 Gilgun-Sherki Y, Melamed E, Mechoulam R, Offen D. The CB1 cannabinoid receptor agonist, HU-210, reduces levodopa-induced rotations in 6-hydroxydopamine-lesioned rats. Pharmacology & Toxicology. 93: 66-70. PMID 12899667 DOI: 10.1034/J.1600-0773.2003.930202.X  0.313
2003 Fride E, Foox A, Rosenberg E, Faigenboim M, Cohen V, Barda L, Blau H, Mechoulam R. Milk intake and survival in newborn cannabinoid CB1 receptor knockout mice: Evidence for a "CB3" receptor European Journal of Pharmacology. 461: 27-34. PMID 12568912 DOI: 10.1016/S0014-2999(03)01295-0  0.784
2002 Mechoulam R, Hanuš L. Cannabidiol: An overview of some chemical and pharmacological aspects. Part I: Chemical aspects Chemistry and Physics of Lipids. 121: 35-43. PMID 12505688 DOI: 10.1016/S0009-3084(02)00144-5  0.301
2002 Ugdyzhekova DS, Krylatov AV, Bernatskaya NA, Maslov LN, Mechoulam R, Pertwee RG. Activation of cannabinoid receptors decreases the area of ischemic myocardial necrosis Bulletin of Experimental Biology and Medicine. 133: 125-126. PMID 12428278 DOI: 10.1023/A:1015526217332  0.338
2002 Mechoulam R, Parker LA, Gallily R. Cannabidiol: An overview of some pharmacological aspects Journal of Clinical Pharmacology. 42: 11S-19S. PMID 12412831 DOI: 10.1002/J.1552-4604.2002.Tb05998.X  0.333
2002 Berry EM, Mechoulam R. Tetrahydrocannabinol and endocannabinoids in feeding and appetite Pharmacology and Therapeutics. 95: 185-190. PMID 12182965 DOI: 10.1016/S0163-7258(02)00257-7  0.354
2002 Howlett AC, Barth F, Bonner TI, Cabral G, Casellas P, Devane WA, Felder CC, Herkenham M, Mackie K, Martin BR, Mechoulam R, Pertwee RG. International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacological Reviews. 54: 161-202. PMID 12037135 DOI: 10.1124/Pr.54.2.161  0.378
2002 Mechoulam R, Panikashvili D, Shohami E. Cannabinoids and brain injury: Therapeutic implications Trends in Molecular Medicine. 8: 58-61. PMID 11815270 DOI: 10.1016/S1471-4914(02)02276-1  0.326
2001 Bisogno T, Hanuš L, De Petrocellis L, Tchilibon S, Ponde DE, Brandi I, Moriello AS, Davis JB, Mechoulam R, Di Marzo V. Molecular targets for cannabidiol and its synthetic analogues: Effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide British Journal of Pharmacology. 134: 845-852. PMID 11606325 DOI: 10.1038/Sj.Bjp.0704327  0.35
2001 Fride E, Ginzburg Y, Breuer A, Bisogno T, Di Marzo V, Mechoulam R. Critical role of the endogenous cannabinoid system in mouse pup suckling and growth European Journal of Pharmacology. 419: 207-214. PMID 11426843 DOI: 10.1016/S0014-2999(01)00953-0  0.776
2001 Mechoulam R, Fride E. Physiology: A hunger for cannabinoids Nature. 410: 763+765. PMID 11298428 DOI: 10.1038/35071214  0.733
2001 Hanus L, Abu-Lafi S, Fride E, Breuer A, Vogel Z, Shalev DE, Kustanovich I, Mechoulam R. 2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor Proceedings of the National Academy of Sciences of the United States of America. 98: 3662-3665. PMID 11259648 DOI: 10.1073/Pnas.061029898  0.782
2000 Malfait AM, Gallily R, Sumariwalla PF, Malik AS, Andreakos E, Mechoulam R, Feldmann M. The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis Proceedings of the National Academy of Sciences of the United States of America. 97: 9561-9566. PMID 10920191 DOI: 10.1073/Pnas.160105897  0.314
2000 Shohami E, Mechoulam R. Dexanabinol (HU-211): A nonpsychotropic cannabinoid with neuroprotective properties Drug Development Research. 50: 211-215. DOI: 10.1002/1098-2299(200007/08)50:3/4<211::Aid-Ddr3>3.0.Co;2-G  0.314
1999 Hanus L, Breuer A, Tchilibon S, Shiloah S, Goldenberg D, Horowitz M, Pertwee RG, Ross RA, Mechoulam R, Fride E. HU-308: a specific agonist for CB(2), a peripheral cannabinoid receptor. Proceedings of the National Academy of Sciences of the United States of America. 96: 14228-33. PMID 10588688 DOI: 10.1073/Pnas.96.25.14228  0.782
1999 Martin BR, Mechoulam R, Razdan RK. Discovery and characterization of endogenous cannabinoids. Life Sciences. 65: 573-95. PMID 10462059 DOI: 10.1016/S0024-3205(99)00281-7  0.384
1998 Mechoulam R, Hanuš L, Fride E. 5 Towards cannabinoid drugs - revisited Progress in Medicinal Chemistry. 35: 199-243. PMID 10795402 DOI: 10.1016/S0079-6468(08)70037-7  0.722
1998 Di Marzo V, Sepe N, De Petrocellis L, Berger A, Crozier G, Fride E, Mechoulam R, Beltramo M, Piomelli D. Trick or treat from food endocannabinoids? [4] (multiple letters) Nature. 396: 636-637. PMID 9872309 DOI: 10.1038/25267  0.745
1998 Mechoulam R, Fride E, Ben-Shabat S, Meiri U, Horowitz M. Carbachol, an acetylcholine receptor agonist, enhances production in rat aorta of 2-arachidonoyl glycerol, a hypotensive endocannabinoid European Journal of Pharmacology. 362: R1-R3. PMID 9865537 DOI: 10.1016/S0014-2999(98)00777-8  0.762
1998 Ben-Shabat S, Fride E, Sheskin T, Tamiri T, Rhee MH, Vogel Z, Bisogno T, De Petrocellis L, Di Marzo V, Mechoulam R. An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity European Journal of Pharmacology. 353: 23-31. PMID 9721036 DOI: 10.1016/S0014-2999(98)00392-6  0.791
1998 Sulcova E, Mechoulam R, Fride E. Biphasic effects of anandamide Pharmacology Biochemistry and Behavior. 59: 347-352. PMID 9476980 DOI: 10.1016/S0091-3057(97)00422-X  0.762
1997 Rhee MH, Vogel Z, Barg J, Bayewitch M, Levy R, Hanuš L, Breuer A, Mechoulam R. Cannabinol derivatives: Binding to cannabinoid receptors and inhibition of adenylylcyclase Journal of Medicinal Chemistry. 40: 3228-3233. PMID 9379442 DOI: 10.1021/Jm970126F  0.357
1997 Bisogno T, Sepe N, De Petrocellis L, Mechoulam R, Di Marzo V. The sleep inducing factor oleamide is produced by mouse neuroblastoma cells Biochemical and Biophysical Research Communications. 239: 473-479. PMID 9344854 DOI: 10.1006/Bbrc.1997.7431  0.319
1997 Mechoulam R, Fride E, Hanuš L, Sheskin T, Bisogno T, Marzo VD, Bayewitch M, Vogel Z. Anandamide may mediate sleep induction [6] Nature. 389: 25-26. PMID 9288961 DOI: 10.1038/37891  0.721
1996 Mechoulam R, Ben Shabat S, Hanuš L, Fride E, Vogel Z, Bayewitch M, Sulcova AE. Endogenous cannabinoid ligands - Chemical and biological studies Journal of Lipid Mediators and Cell Signalling. 14: 45-49. PMID 8906544 DOI: 10.1016/0929-7855(96)01507-6  0.786
1996 Fride E, Mechoulam R. Ontogenetic development of the response to anandamide and delta 9-tetrahydrocannabinol in mice. Brain Research. Developmental Brain Research. 95: 131-4. PMID 8873985 DOI: 10.1016/0165-3806(96)00087-9  0.754
1996 Mechoulam R, Ben Shabat S, Hanuš L, Fride E, Bayewitch M, Vogel Z. Endogenous cannabinoid ligands Advances in Experimental Medicine and Biology. 402: 95-100. PMID 8787649 DOI: 10.1007/978-1-4613-0407-4_14  0.751
1996 Fride E, Mechoulam R. Developmental aspects of anandamide: ontogeny of response and prenatal exposure. Psychoneuroendocrinology. 21: 157-72. PMID 8774060 DOI: 10.1016/0306-4530(95)00039-9  0.77
1996 Bayewitch M, Rhee MH, Avidor-Reiss T, Breuer A, Mechoulam R, Vogel Z. (-)-Delta9-tetrahydrocannabinol antagonizes the peripheral cannabinoid receptor-mediated inhibition of adenylyl cyclase. The Journal of Biological Chemistry. 271: 9902-5. PMID 8626625 DOI: 10.1074/Jbc.271.17.9902  0.393
1996 Shohami E, Weidenfeld J, Ovadia H, Vogel Z, Hanuš L, Fride E, Breuer A, Ben-Shabat S, Sheskin T, Mechoulam R. Endogenous and synthetic cannabinoids: Recent advances Cns Drug Reviews. 2: 429-451. DOI: 10.1111/J.1527-3458.1996.Tb00310.X  0.741
1995 Barg J, Fride E, Hanus L, Levy R, Matus-Leibovitch N, Heldman E, Bayewitch M, Mechoulam R, Vogel Z. Cannabinomimetic behavioral effects of and adenylate cyclase inhibition by two new endogenous anandamides. European Journal of Pharmacology. 287: 145-52. PMID 8749028 DOI: 10.1016/0014-2999(95)00487-4  0.773
1995 Ovadia H, Wohlman A, Mechoulam R, Weidenfeld J. Characterization of the hypothermic effect of the synthetic cannabinoid HU-210 in the rat. Relation to the adrenergic system and endogenous pyrogens. Neuropharmacology. 34: 175-180. PMID 7617143 DOI: 10.1016/0028-3908(94)00133-D  0.353
1995 Mechoulam R, Ben-Shabat S, Hanus L, Ligumsky M, Kaminski NE, Schatz AR, Gopher A, Almog S, Martin BR, Compton DR. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochemical Pharmacology. 50: 83-90. PMID 7605349 DOI: 10.1016/0006-2952(95)00109-D  0.355
1995 Bayewitch M, Avidor-Reiss T, Levy R, Barg J, Mechoulam R, Vogel Z. The peripheral cannabinoid receptor: adenylate cyclase inhibition and G protein coupling. Febs Letters. 375: 143-7. PMID 7498464 DOI: 10.1016/0014-5793(95)01207-U  0.382
1994 Weidenfeld J, Feldman S, Mechoulam R. Effect of the brain constituent anandamide, a cannabinoid receptor agonist, on the hypothalamo-pituitary-adrenal axis in the rat. Neuroendocrinology. 59: 110-112. PMID 8127398 DOI: 10.1159/000126646  0.353
1994 Schuel H, Goldstein E, Mechoulam R, Zimmerman AM, Zimmerman S. Anandamide (arachidonylethanolamide), a brain cannabinoid receptor agonist, reduces sperm fertilizing capacity in sea urchins by inhibiting the acrosome reaction. Proceedings of the National Academy of Sciences of the United States of America. 91: 7678-82. PMID 8052642 DOI: 10.1073/Pnas.91.16.7678  0.336
1994 Mechoulam R, Hanuš L, Martin BR. Search for endogenous ligands of the cannabinoid receptor. Biochemical Pharmacology. 48: 1537-1544. PMID 7980618 DOI: 10.1016/0006-2952(94)90197-X  0.325
1994 Rodríguez de Fonseca F, Martín Calderón JL, Mechoulam R, Navarro M. Repeated stimulation of D1 dopamine receptors enhances (-)-11-hydroxy-delta 8-tetrahydrocannabinol-dimethyl-heptyl-induced catalepsy in male rats. Neuroreport. 5: 761-5. PMID 7912554 DOI: 10.1097/00001756-199403000-00006  0.339
1994 Wirguin I, Mechoulam R, Breuer A, Schezen E, Weidenfeld J, Brenner T. Suppression of experimetal autoimmune encephalomyelitis by cannabinoids Immunopharmacology. 28: 209-214. PMID 7852052 DOI: 10.1016/0162-3109(94)90056-6  0.318
1994 Mechoulam R, Vogel Z, Barg J. CNS Cannabinoid Receptors Cns Drugs. 2: 255-260. DOI: 10.2165/00023210-199402040-00001  0.347
1993 Vogel Z, Barg J, Levy R, Saya D, Heldman E, Mechoulam R. Anandamide, a brain endogenous compound, interacts specifically with cannabinoid receptors and inhibits adenylate cyclase. Journal of Neurochemistry. 61: 352-355. PMID 8515284 DOI: 10.1111/J.1471-4159.1993.Tb03576.X  0.378
1993 Hanus L, Gopher A, Almog S, Mechoulam R. Two new unsaturated fatty acid ethanolamides in brain that bind to the cannabinoid receptor Journal of Medicinal Chemistry. 36: 3032-3034. PMID 8411021 DOI: 10.1021/Jm00072A026  0.379
1993 Fride E, Mechoulam R. Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent. European Journal of Pharmacology. 231: 313-4. PMID 8384116 DOI: 10.1016/0014-2999(93)90468-W  0.783
1993 Nadler V, Mechoulam R, Sokolovsky M. Blockade of45Ca2+ influx through theN-methyl-d-aspartate receptor ion channel by the non-psychoactive cannabinoid HU-211 Brain Research. 622: 79-85. PMID 8242387 DOI: 10.1016/0006-8993(93)90804-V  0.306
1993 Nadler V, Mechoulam R, Sokolovsky M. The non-psychotropic cannabinoid (+)-(3S,4S)-7-hydroxy-Δ6-tetrahydrocannabinol 1,1-dimethylheptyl (HU-211) attenuates receptor-mediated neurotoxicity in primary cultures of rat forebrain Neuroscience Letters. 162: 43-45. PMID 8121633 DOI: 10.1016/0304-3940(93)90555-Y  0.314
1992 Burstein SH, Audette CA, Breuer A, Devane WA, Colodner S, Doyle SA, Mechoulam R. Synthetic nonpsychotropic cannabinoids with potent antiinflammatory, analgesic, and leukocyte antiadhesion activities Journal of Medicinal Chemistry. 35: 3135-3141. PMID 1507202 DOI: 10.1021/Jm00095A007  0.354
1992 Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, Gibson D, Mandelbaum A, Etinger A, Mechoulam R. Isolation And Structure Of A Brain Constituent That Binds To The Cannabinoid Receptor Science. 258: 1946-1949. PMID 1470919 DOI: 10.1126/Science.1470919  0.366
1992 Devane WA, Breuer A, Sheskin T, Järbe TU, Eisen MS, Mechoulam R. A novel probe for the cannabinoid receptor. Journal of Medicinal Chemistry. 35: 2065-9. PMID 1317925 DOI: 10.1021/Jm00089A018  0.357
1991 Mechoulam R, Devane WA, Breuer A, Zahalka J. A random walk through a cannabis field. Pharmacology, Biochemistry and Behavior. 40: 461-464. PMID 1806938 DOI: 10.1016/0091-3057(91)90347-5  0.353
1991 Martin BR, Compton DR, Thomas BF, Prescott WR, Little PJ, Razdan RK, Johnson MR, Melvin LS, Mechoulam R, Ward SJ. Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs. Pharmacology, Biochemistry, and Behavior. 40: 471-8. PMID 1666911 DOI: 10.1016/0091-3057(91)90349-7  0.319
1991 Zeltser R, Seltzer Z, Eisen A, Feigenbaum JJ, Mechoulam R. Suppression of neuropathic pain behavior in rats by a non-psychotropic synthetic cannabinoid with NMDA receptor-blocking properties. Pain. 47: 95-103. PMID 1663228 DOI: 10.1016/0304-3959(91)90016-Q  0.341
1990 Howlett AC, Champion TM, Wilken GH, Mechoulam R. Stereochemical effects of 11-OH-Δ8-tetrahydrocannabinol-dimethylheptyl to inhibit adenylate cyclase and bind to the cannabinoid receptor Neuropharmacology. 29: 161-165. PMID 2158635 DOI: 10.1016/0028-3908(90)90056-W  0.34
1990 Eisen A, Seltzer Z, Netzach M, Zeltser R, Ginzburg R, Feigenbaum J, Richmond S, Mechoulam R. Suppression of deafferentation-induced chronic pain behavior in the rat by HU211 — An anti-nociceptive synthetic cannabinoid with nmda receptor-blocking properties Pain. 41. DOI: 10.1016/0304-3959(90)92477-8  0.307
1989 Feigenbaum JJ, Bergmann F, Richmond SA, Mechoulam R, Nadler V, Kloog Y, Sokolovsky M. Nonpsychotropic cannabinoid acts as a functional N-methyl-D-aspartate receptor blocker. Proceedings of the National Academy of Sciences of the United States of America. 86: 9584-7. PMID 2556719 DOI: 10.1073/Pnas.86.23.9584  0.34
1982 Leite JR, Carlini EA, Lander N, Mechoulam R. Anticonvulsant effects of the (-) and (+)isomers of cannabidiol and their dimethylheptyl homologs. Pharmacology. 24: 141-6. PMID 7071126 DOI: 10.1159/000137588  0.316
1980 Cordova T, Ayalon D, Lander N, Mechoulam R, Nir I, Puder M, Lindner HR. The ovulation blocking effect of cannabinoids: structure-activity relationships. Psychoneuroendocrinology. 5: 53-62. PMID 6248914 DOI: 10.1016/0306-4530(80)90009-8  0.315
1974 Houry S, Mechoulam R, Fowler PJ, Macko E, Loev B. Benzoxocin and benzoxonin derivatives. Novel groups of terpenophenols with central nervous system activity. Journal of Medicinal Chemistry. 17: 287-293. PMID 1159719 DOI: 10.1021/Jm00243A020  0.302
1965 Pelletier SW, Adityachaudhury N, Tomaz M, Reynolds JJ, Mechoulam R. The structure of senegenic acid, a nortriterpene artifact from Polygala senega. The Journal of Organic Chemistry. 30: 4234-47. PMID 5846174  0.402
1964 Sondheimer F, Mechoulam R, Sprecher M. The synthesis of 19-hydroxy-10-alpha-testosterone. Tetrahedron. 20: 2473-85. PMID 5879223 DOI: 10.1016/S0040-4020(01)90827-0  0.469
1960 Sondheimer F, Burstein S, Mechoulam R. Syntheses in the cardiac aglycone field. III. The conversion of a 14α- to a 14β-hydroxy group in the androstane series. The ultraviolet spectra of Δ15-androsten-17-ones Journal of the American Chemical Society. 82: 3209-3214. DOI: 10.1021/Ja01497A055  0.456
1960 Sondheimer F, Mechoulam R, Sprecher M. 19-hydroxy-10-isotestosterone Tetrahedron Letters. 1: 38-44. DOI: 10.1016/S0040-4039(01)99376-1  0.482
1959 Sondheimer F, Mechoulam R. Notes. The Dies-Alder Reaction of Steroidal 20-Methylene-Δ16-pregnene Derivatives with Maleic Anhydride Journal of Organic Chemistry. 24: 106-107. DOI: 10.1021/Jo01083A600  0.47
1958 Mechoulam R, Sondheimer F. The Wittig Reaction with Fluorenone. Formation of Cyclopropane Derivatives Journal of the American Chemical Society. 80: 4386-4388. DOI: 10.1021/Ja01549A069  0.458
1958 Sondheimer F, Mechoulam R. Further Aspects of the Wittig Reaction in the Steroid Series. 20-Dehydrocholesterol and 20-Isocholesterol Journal of the American Chemical Society. 80: 3087-3090. DOI: 10.1021/Ja01545A046  0.46
1957 Sondheimer F, Mechoulam R. Synthesis of Steroidal Methylene Compounds by the Wittig Reaction1 Journal of the American Chemical Society. 79: 5029-5033. DOI: 10.1021/Ja01575A054  0.482
Show low-probability matches.